{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:45:51Z","timestamp":1782708351206,"version":"3.54.5"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11064-026-04765-z","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:36:13Z","timestamp":1777908973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hippocampal Lipocalin-2 in T2DM Associated Neurodegeneration: A Therapeutic Perspective"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5512-0443","authenticated-orcid":false,"given":"Baivhabee","family":"Panigrahy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0345-5081","authenticated-orcid":false,"given":"Arghya","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-1483","authenticated-orcid":false,"given":"Santosh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"9","key":"4765_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.4103\/2230-8210.105568","volume":"16","author":"TH Meek","year":"2012","unstructured":"Meek TH, Morton GJ (2012) Leptin, diabetes, and the brain. Indian J Endocrinol Metab 16(9):534\u2013542. https:\/\/doi.org\/10.4103\/2230-8210.105568","journal-title":"Indian J Endocrinol Metab"},{"issue":"10","key":"4765_CR2","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2337\/diab.38.10.1203","volume":"38","author":"RL Engerman","year":"1989","unstructured":"Engerman RL (1989) Pathogenesis of diabetic retinopathy. Diabetes 38(10):1203\u20131206. https:\/\/doi.org\/10.2337\/diab.38.10.1203","journal-title":"Diabetes"},{"issue":"1","key":"4765_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3181\/0705-mr-134","volume":"233","author":"YS Kanwar","year":"2008","unstructured":"Kanwar YS et al (2008) Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med 233(1):4\u201311. https:\/\/doi.org\/10.3181\/0705-mr-134","journal-title":"Exp Biol Med"},{"key":"4765_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.01038","volume":"12","author":"M Richner","year":"2019","unstructured":"Richner M et al (2019) Functional and structural changes of the blood-nerve-barrier in diabetic neuropathy. Front Neurosci 12:1038. https:\/\/doi.org\/10.3389\/fnins.2018.01038","journal-title":"Front Neurosci"},{"issue":"1","key":"4765_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.47672\/ejb.409","volume":"4","author":"Y Mukhtar","year":"2019","unstructured":"Mukhtar Y et al (2019) A modern overview on diabetes mellitus: a chronic endocrine disorder. European J Biol 4(1):1\u201314. https:\/\/doi.org\/10.47672\/ejb.409","journal-title":"European J Biol"},{"issue":"12","key":"4765_CR6","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.metabol.2015.09.002","volume":"64","author":"K Kaul","year":"2015","unstructured":"Kaul K, Apostolopoulou M, Roden M (2015) Insulin resistance in type 1 diabetes mellitus. Metabolism 64(12):1629\u20131639. https:\/\/doi.org\/10.1016\/j.metabol.2015.09.002","journal-title":"Metabolism"},{"issue":"3","key":"4765_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","volume":"17","author":"BO Roep","year":"2020","unstructured":"Roep BO et al (2020) Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system?). Nat Rev Endocrinol 17(3):150\u2013161. https:\/\/doi.org\/10.1038\/s41574-020-00443-4","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"4765_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0002-9149(02)02553-5","volume":"90","author":"BJ Goldstein","year":"2002","unstructured":"Goldstein BJ (2002) Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol 90(5):3\u201310. https:\/\/doi.org\/10.1016\/s0002-9149(02)02553-5","journal-title":"Am J Cardiol"},{"issue":"3","key":"4765_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","volume":"94","author":"D Whiting","year":"2011","unstructured":"Whiting D et al (2011) IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94(3):311\u2013321. https:\/\/doi.org\/10.1016\/j.diabres.2011.10.029","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"4765_CR10","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00125-006-0221-8","volume":"49","author":"GS Mijnhout","year":"2006","unstructured":"Mijnhout GS et al (2006) Diabetic encephalopathy: a concept in need of a definition. Diabetologia 49(6):1447\u20131448. https:\/\/doi.org\/10.1007\/s00125-006-0221-8","journal-title":"Diabetologia"},{"key":"4765_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuroscience.2023.02.011","volume":"515","author":"W Zhang","year":"2023","unstructured":"Zhang W, Chen S, Xianghua Z (2023) Research progress on Lipocalin-2 in diabetic encephalopathy. Neuroscience 515:74\u201382. https:\/\/doi.org\/10.1016\/j.neuroscience.2023.02.011","journal-title":"Neuroscience"},{"issue":"s2","key":"4765_CR12","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.3233\/JAD-2012-111433","volume":"30","author":"JA Luchsinger","year":"2012","unstructured":"Luchsinger JA (2012) Type 2 diabetes and cognitive impairment: linking mechanisms. JAD 30(s2):S185\u2013S198. https:\/\/doi.org\/10.3233\/JAD-2012-111433","journal-title":"JAD"},{"issue":"22","key":"4765_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212366","volume":"22","author":"FC Pignalosa","year":"2021","unstructured":"Pignalosa FC et al (2021) Diabetes and cognitive impairment: a role for glucotoxicity and dopaminergic dysfunction. Int J Mol Sci 22(22):12366. https:\/\/doi.org\/10.3390\/ijms222212366","journal-title":"Int J Mol Sci"},{"key":"4765_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2019.00025","volume":"10","author":"A Bhusal","year":"2019","unstructured":"Bhusal A et al (2019) Role of hippocampal Lipocalin-2 in experimental diabetic encephalopathy. Front Endocrinol 10:25\u201325. https:\/\/doi.org\/10.3389\/fendo.2019.00025","journal-title":"Front Endocrinol"},{"issue":"1","key":"4765_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000026190","volume":"18","author":"TG Lukovits","year":"1999","unstructured":"Lukovits TG et al (1999) Diabetes mellitus and cerebrovascular disease. Neuroepidemiology 18(1):1\u201314. https:\/\/doi.org\/10.1159\/000026190","journal-title":"Neuroepidemiology"},{"key":"4765_CR16","doi-asserted-by":"publisher","first-page":"102158","DOI":"10.1155\/2014\/102158","volume":"2014","author":"M Muriach","year":"2014","unstructured":"Muriach M et al (2014) Diabetes and the brain: oxidative stress, inflammation, and autophagy. Oxid Med Cell Longev 2014:102158\u2013102158. https:\/\/doi.org\/10.1155\/2014\/102158","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"4765_CR17","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/mas.20090","volume":"25","author":"A Lapolla","year":"2006","unstructured":"Lapolla A et al (2006) The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update. Mass Spectrom Rev 25(5):775\u2013797. https:\/\/doi.org\/10.1002\/mas.20090","journal-title":"Mass Spectrom Rev"},{"issue":"3","key":"4765_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/nejm198001173020301","volume":"302","author":"BD Given","year":"1980","unstructured":"Given BD et al (1980) Diabetes due to secretion of an abnormal insulin. N Engl J Med 302(3):129\u2013135. https:\/\/doi.org\/10.1056\/nejm198001173020301","journal-title":"N Engl J Med"},{"key":"4765_CR19","unstructured":"Singh R, Rao H, Singh TG (2020) Advanced glycated end products (AGES) in diabetes and its complications. An insight"},{"key":"4765_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fnagi.2015.00209","volume":"7","author":"M G\u00f3rska-Ciebiada","year":"2015","unstructured":"G\u00f3rska-Ciebiada M et al (2015) C-Reactive Protein, Advanced Glycation End Products, and their receptor in Type 2 diabetic, elderly patients with Mild Cognitive Impairment. Front Aging Neurosci 7:209\u2013209. https:\/\/doi.org\/10.3389\/fnagi.2015.00209","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"4765_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/jad-180314","volume":"65","author":"R Chen","year":"2018","unstructured":"Chen R et al (2018) Morphological and pathological characteristics of brain in Diabetic Encephalopathy. J Alzheimers Dis 65(1):15\u201328. https:\/\/doi.org\/10.3233\/jad-180314","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"4765_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Biessels GJ, Despa F, Despa F, Despa F (2018) Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol 14(10):591\u2013604. https:\/\/doi.org\/10.1038\/s41574-018-0048-7","journal-title":"Nat Rev Endocrinol"},{"key":"4765_CR23","doi-asserted-by":"publisher","first-page":"638112","DOI":"10.3389\/fphys.2021.638112","volume":"12","author":"A Bhusal","year":"2021","unstructured":"Bhusal A, Bhusal A, Lee W-H, Lee W-H, Suk K, Suk K (2021) Lipocalin-2 in diabetic complications of the nervous system: physiology, pathology, and beyond. Front Physiol 12:638112\u2013638112. https:\/\/doi.org\/10.3389\/fphys.2021.638112","journal-title":"Front Physiol"},{"issue":"1","key":"4765_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/endocrines6010004","volume":"6","author":"E Lindstrom","year":"2025","unstructured":"Lindstrom E, Deis J, Bernlohr DA, Chen X (2025) Lipocalin 2 in obesity and diabetes: insights into its role in energy metabolism. Endocrines 6(1):4. https:\/\/doi.org\/10.3390\/endocrines6010004","journal-title":"Endocrines"},{"issue":"4","key":"4765_CR25","doi-asserted-by":"publisher","first-page":"L726","DOI":"10.1152\/ajplung.00080.2021","volume":"321","author":"S Guardado","year":"2021","unstructured":"Guardado S, Ojeda-Ju\u00e1rez D, Kaul M, Nordgren TM (2021) Comprehensive review of Lipocalin 2-mediated effects in lung inflammation. Am J Physiol Lung Cell Mol Physiol 321(4):L726\u2013L733. https:\/\/doi.org\/10.1152\/ajplung.00080.2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"12","key":"4765_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124365","volume":"21","author":"GS Santiago-S\u00e1nchez","year":"2020","unstructured":"Santiago-S\u00e1nchez GS et al (2020) Biological functions and therapeutic potential of Lipocalin 2 in cancer. Int J Mol Sci 21(12):4365. https:\/\/doi.org\/10.3390\/ijms21124365","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4765_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1530\/JME-18-0017","volume":"61","author":"JA Deis","year":"2018","unstructured":"Deis JA, Guo H, Wu Y, Liu C, Bernlohr DA, Chen X (2018) Lipocalin 2 regulates retinoic acid-induced activation of beige adipocytes. J Mol Endocrinol 61(3):115\u2013126. https:\/\/doi.org\/10.1530\/JME-18-0017","journal-title":"J Mol Endocrinol"},{"issue":"4","key":"4765_CR28","doi-asserted-by":"publisher","first-page":"872","DOI":"10.2337\/db09-1541","volume":"59","author":"IKM Law","year":"2010","unstructured":"Law IKM et al (2010) Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes 59(4):872\u2013882. https:\/\/doi.org\/10.2337\/db09-1541","journal-title":"Diabetes"},{"issue":"10","key":"4765_CR29","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1073\/pnas.1218497110","volume":"110","author":"F Bi","year":"2013","unstructured":"Bi F et al (2013) Reactive astrocytes secrete lcn2 to promote neuron death. Proc Natl Acad Sci U S A 110(10):4069\u20134074. https:\/\/doi.org\/10.1073\/pnas.1218497110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4765_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114915","volume":"380","author":"X Wang","year":"2024","unstructured":"Wang X et al (2024) Astrocyte-derived lipocalin 2 promotes inflammation and scarring after spinal cord injury by activating SMAD in mice. Exp Neurol 380:114915. https:\/\/doi.org\/10.1016\/j.expneurol.2024.114915","journal-title":"Exp Neurol"},{"issue":"1","key":"4765_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1373\/clinchem.2006.075614","volume":"53","author":"Y Wang","year":"2007","unstructured":"Wang Y et al (2007) Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 53(1):34\u201341. https:\/\/doi.org\/10.1373\/clinchem.2006.075614","journal-title":"Clin Chem"},{"key":"4765_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fphys.2016.00430","volume":"7","author":"A Asimakopoulou","year":"2016","unstructured":"Asimakopoulou A, Weiskirchen S, Weiskirchen R (2016) Lipocalin 2 (LCN2) expression in hepatic malfunction and therapy. Front Physiol 7:430\u2013430. https:\/\/doi.org\/10.3389\/fphys.2016.00430","journal-title":"Front Physiol"},{"issue":"8","key":"4765_CR33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3109\/1354750x.2015.1123354","volume":"20","author":"V Abella","year":"2015","unstructured":"Abella V et al (2015) The potential of lipocalin-2\/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers 20(8):565\u2013571. https:\/\/doi.org\/10.3109\/1354750x.2015.1123354","journal-title":"Biomarkers"},{"issue":"1","key":"4765_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1615\/critrevimmunol.2015012127","volume":"35","author":"S Lee","year":"2015","unstructured":"Lee S, Jha MK, Suk K (2015) Lipocalin-2 in the inflammatory activation of brain astrocytes. Crit Rev Immunol 35(1):77\u201384. https:\/\/doi.org\/10.1615\/critrevimmunol.2015012127","journal-title":"Crit Rev Immunol"},{"issue":"7","key":"4765_CR35","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2005.10.027","volume":"123","author":"LR Devireddy","year":"2005","unstructured":"Devireddy LR et al (2005) A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123(7):1293\u20131305. https:\/\/doi.org\/10.1016\/j.cell.2005.10.027","journal-title":"Cell"},{"issue":"5","key":"4765_CR36","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.4049\/jimmunol.179.5.3231","volume":"179","author":"S Lee","year":"2007","unstructured":"Lee S et al (2007) A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J Immunol 179(5):3231\u20133241. https:\/\/doi.org\/10.4049\/jimmunol.179.5.3231","journal-title":"J Immunol"},{"issue":"1","key":"4765_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1523\/jneurosci.5273-08.2009","volume":"29","author":"S Lee","year":"2009","unstructured":"Lee S et al (2009) Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J Neurosci 29(1):234\u2013249. https:\/\/doi.org\/10.1523\/jneurosci.5273-08.2009","journal-title":"J Neurosci"},{"issue":"8","key":"4765_CR38","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/jcbfm.2014.83","volume":"34","author":"M Jin","year":"2014","unstructured":"Jin M et al (2014) Lipocalin-2 deficiency attenuates neuroinflammation and brain injury after transient middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 34(8):1306\u20131314. https:\/\/doi.org\/10.1038\/jcbfm.2014.83","journal-title":"J Cereb Blood Flow Metab"},{"key":"4765_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neubiorev.2014.12.006","volume":"49","author":"MK Jha","year":"2015","unstructured":"Jha MK et al (2015) Diverse functional roles of lipocalin-2 in the central nervous system. Neurosci Biobehav Rev 49:135\u2013156. https:\/\/doi.org\/10.1016\/j.neubiorev.2014.12.006","journal-title":"Neurosci Biobehav Rev"},{"key":"4765_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112002","volume":"142","author":"S Al Jaberi","year":"2021","unstructured":"Al Jaberi S et al (2021) Lipocalin-2: structure, function, distribution and role in metabolic disorders. Biomed Pharmacother 142:112002. https:\/\/doi.org\/10.1016\/j.biopha.2021.112002","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"4765_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/jmr.300080304","volume":"8","author":"DR Flower","year":"1995","unstructured":"Flower DR (1995) Multiple molecular recognition properties of the lipocalin protein family. J Mol Recognit 8(3):185\u2013195. https:\/\/doi.org\/10.1002\/jmr.300080304","journal-title":"J Mol Recognit"},{"issue":"1\u20132","key":"4765_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0167-4838(00)00148-5","volume":"1482","author":"DR Flower","year":"2000","unstructured":"Flower DR, North ACT, Sansom CE (2000) The lipocalin protein family: structural and sequence overview. Biochim et Biophys Acta (BBA) - Protein Struct Mol Enzymol 1482(1\u20132):9\u201324. https:\/\/doi.org\/10.1016\/S0167-4838(00)00148-5","journal-title":"Biochim et Biophys Acta (BBA) - Protein Struct Mol Enzymol"},{"issue":"8","key":"4765_CR43","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1021\/bi992215v","volume":"39","author":"DH Goetz","year":"2000","unstructured":"Goetz DH et al (2000) Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry 39(8):1935\u20131941. https:\/\/doi.org\/10.1021\/bi992215v","journal-title":"Biochemistry"},{"issue":"5","key":"4765_CR44","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/s1097-2765(02)00710-4","volume":"10","author":"J Yang","year":"2002","unstructured":"Yang J et al (2002) An iron delivery pathway mediated by a lipocalin. Mol Cell 10(5):1045\u20131056. https:\/\/doi.org\/10.1016\/s1097-2765(02)00710-4","journal-title":"Mol Cell"},{"issue":"7019","key":"4765_CR45","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03104","volume":"432","author":"TH Flo","year":"2004","unstructured":"Flo TH et al (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432(7019):917\u2013921. https:\/\/doi.org\/10.1038\/nature03104","journal-title":"Nature"},{"key":"4765_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02594","volume":"10","author":"Q Wang","year":"2019","unstructured":"Wang Q et al (2019) Lipocalin 2 protects against Escherichia coli infection by modulating neutrophil and macrophage function. Front Immunol 10:2594. https:\/\/doi.org\/10.3389\/fimmu.2019.02594","journal-title":"Front Immunol"},{"issue":"14","key":"4765_CR47","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1016\/s0021-9258(18)82217-7","volume":"268","author":"L Kjeldsen","year":"1993","unstructured":"Kjeldsen L et al (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268(14):10425\u201310432. https:\/\/doi.org\/10.1016\/s0021-9258(18)82217-7","journal-title":"J Biol Chem"},{"issue":"2","key":"4765_CR48","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/hep.27447","volume":"61","author":"M Xu","year":"2015","unstructured":"Xu M et al (2015) Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL\u20106\/STAT3. Hepatology 61(2):692\u2013702. https:\/\/doi.org\/10.1002\/hep.27447","journal-title":"Hepatology"},{"issue":"3","key":"4765_CR49","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.4049\/jimmunol.151.3.1535","volume":"151","author":"L Meheus","year":"1993","unstructured":"Meheus L et al (1993) Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. J Immunol 151(3):1535\u20131547. https:\/\/doi.org\/10.4049\/jimmunol.151.3.1535","journal-title":"J Immunol"},{"issue":"1","key":"4765_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1006\/geno.1997.4896","volume":"45","author":"JB Cowland","year":"1997","unstructured":"Cowland JB, Cowland JB, Cowland JB, Borregaard N, Borregaard N, Borregaard N (1997) Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase associated lipocalin from humans. Genomics 45(1):17\u201323. https:\/\/doi.org\/10.1006\/geno.1997.4896","journal-title":"Genomics"},{"issue":"7645","key":"4765_CR51","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nature21697","volume":"543","author":"I Mosialou","year":"2017","unstructured":"Mosialou I et al (2017) MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature 543(7645):385\u2013390. https:\/\/doi.org\/10.1038\/nature21697","journal-title":"Nature"},{"key":"4765_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.638112","volume":"12","author":"A Bhusal","year":"2021","unstructured":"Bhusal A, Lee W-H, Suk K (2021) Lipocalin-2 in diabetic complications of the nervous system: physiology, pathology, and beyond. Front Physiol 12:638112. https:\/\/doi.org\/10.3389\/fphys.2021.638112","journal-title":"Front Physiol"},{"issue":"40","key":"4765_CR53","doi-asserted-by":"publisher","first-page":"37258","DOI":"10.1074\/jbc.M106089200","volume":"276","author":"L Yan","year":"2001","unstructured":"Yan L, Borregaard N, Kjeldsen L, Moses MA (2001) The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of Gelatinase B\/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). J Biol Chem 276(40):37258\u201337265. https:\/\/doi.org\/10.1074\/jbc.M106089200","journal-title":"J Biol Chem"},{"issue":"4","key":"4765_CR54","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.4049\/jimmunol.1200892","volume":"189","author":"G Srinivasan","year":"2012","unstructured":"Srinivasan G et al (2012) Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis. J Immunol 189(4):1911\u20131919. https:\/\/doi.org\/10.4049\/jimmunol.1200892","journal-title":"J Immunol"},{"issue":"6","key":"4765_CR55","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1210\/me.2007-0420","volume":"22","author":"J Zhang","year":"2008","unstructured":"Zhang J, Wu Y, Zhang Y, LeRoith D, Bernlohr DA, Chen X (2008) The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol 22(6):1416\u20131426. https:\/\/doi.org\/10.1210\/me.2007-0420","journal-title":"Mol Endocrinol"},{"issue":"8","key":"4765_CR56","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1080\/15548627.2023.2180202","volume":"19","author":"B-K Jung","year":"2023","unstructured":"Jung B-K et al (2023) Reduced secretion of LCN2 (lipocalin 2) from reactive astrocytes through autophagic and proteasomal regulation alleviates inflammatory stress and neuronal damage. Autophagy 19(8):2296\u20132317. https:\/\/doi.org\/10.1080\/15548627.2023.2180202","journal-title":"Autophagy"},{"issue":"9","key":"4765_CR57","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1074\/jbc.M113.532234","volume":"289","author":"P Zhao","year":"2014","unstructured":"Zhao P, Elks CM, Stephens JM (2014) The induction of lipocalin-2 protein expression in vivo and in vitro. J Biol Chem 289(9):5960\u20135969. https:\/\/doi.org\/10.1074\/jbc.M113.532234","journal-title":"J Biol Chem"},{"issue":"6","key":"4765_CR58","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.ajkd.2009.07.020","volume":"54","author":"M Haase","year":"2009","unstructured":"Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A (2009) Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis 54(6):1012\u20131024. https:\/\/doi.org\/10.1053\/j.ajkd.2009.07.020","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"4765_CR59","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1097\/01.ASN.0000145013.44578.45","volume":"15","author":"J Mishra","year":"2004","unstructured":"Mishra J et al (2004) Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 15(12):3073\u20133082. https:\/\/doi.org\/10.1097\/01.ASN.0000145013.44578.45","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"4765_CR60","doi-asserted-by":"publisher","first-page":"567","DOI":"10.32604\/or.2024.051672","volume":"33","author":"B Huang","year":"2025","unstructured":"Huang B, Jia Z, Chen Y, Fu C, Chen M, Su Z (2025) Oncogenic and tumor-suppressive roles of Lipocalin 2 (LCN2) in tumor progression. OR 33(3):567\u2013575. https:\/\/doi.org\/10.32604\/or.2024.051672","journal-title":"OR"},{"issue":"10","key":"4765_CR61","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.2337\/db07-0007","volume":"56","author":"Q-W Yan","year":"2007","unstructured":"Yan Q-W et al (2007) The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56(10):2533\u20132540. https:\/\/doi.org\/10.2337\/db07-0007","journal-title":"Diabetes"},{"issue":"8","key":"4765_CR62","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00109-009-0486-8","volume":"87","author":"V Catal\u00e1n","year":"2009","unstructured":"Catal\u00e1n V et al (2009) Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans. J Mol Med 87(8):803\u2013813. https:\/\/doi.org\/10.1007\/s00109-009-0486-8","journal-title":"J Mol Med"},{"key":"4765_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1365602","volume":"15","author":"M Krizanac","year":"2024","unstructured":"Krizanac M, Mass Sanchez PB, Weiskirchen R, Schr\u00f6der SK (2024) Overview of the expression patterns and roles of lipocalin 2 in the reproductive system. Front Endocrinol 15:1365602. https:\/\/doi.org\/10.3389\/fendo.2024.1365602","journal-title":"Front Endocrinol"},{"issue":"11","key":"4765_CR64","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1530\/EC-21-0290","volume":"10","author":"X Zhang","year":"2021","unstructured":"Zhang X et al (2021) The association of elevated serum lipocalin 2 levels with diabetic peripheral neuropathy in type 2 diabetes. Endocr Connect 10(11):1403\u20131409. https:\/\/doi.org\/10.1530\/EC-21-0290","journal-title":"Endocr Connect"},{"issue":"4","key":"4765_CR65","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4239\/wjd.v6.i4.598","volume":"6","author":"I Hameed","year":"2015","unstructured":"Hameed I, Masoodi SR, Mir SA, Nabi M, Ghazanfar K, Ganai BA (2015) Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World J Diabetes 6(4):598. https:\/\/doi.org\/10.4239\/wjd.v6.i4.598","journal-title":"World J Diabetes"},{"issue":"1","key":"4765_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/endocrines6010004","volume":"6","author":"E Lindstrom","year":"2025","unstructured":"Lindstrom E, Deis J, Bernlohr DA, Chen X (2025) Lipocalin 2 in obesity and diabetes: Insights into its role in energy metabolism. Endocrines 6(1):4. https:\/\/doi.org\/10.3390\/endocrines6010004","journal-title":"Endocrines"},{"key":"4765_CR67","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100543RR","author":"AK Aladhami","year":"2021","unstructured":"Aladhami AK et al (2021) Macrophage tumor necrosis factor-alpha deletion does not protect against obesity\u2010associated metabolic dysfunction,. FASEB J. https:\/\/doi.org\/10.1096\/fj.202100543RR","journal-title":"FASEB J"},{"issue":"1","key":"4765_CR68","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1742-2094-8-124","volume":"8","author":"JPK Ip","year":"2011","unstructured":"Ip JPK et al (2011) Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration. J Neuroinflamm 8(1):124\u2013124. https:\/\/doi.org\/10.1186\/1742-2094-8-124","journal-title":"J Neuroinflamm"},{"key":"4765_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.283","author":"T Furukawa","year":"2017","unstructured":"Furukawa T et al (2017) Chronic diazepam administration increases the expression of Lcn2 in the CNS.,. Pharmacol Res Perspect. https:\/\/doi.org\/10.1002\/prp2.283","journal-title":"Pharmacol Res Perspect"},{"key":"4765_CR70","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-023-03365-y","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) Association between lipocalin-2 levels and diabetic retinopathy in patients with overweight\/obese type 2 diabetes mellitus,. Ir J Med Sci. https:\/\/doi.org\/10.1007\/s11845-023-03365-y","journal-title":"Ir J Med Sci"},{"issue":"45","key":"4765_CR71","doi-asserted-by":"publisher","first-page":"18436","DOI":"10.1073\/pnas.1107936108","volume":"108","author":"M Mucha","year":"2011","unstructured":"Mucha M, Skrzypiec AE, Schiavon E, Attwood BK, Kucerova E, Pawlak R (2011) Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation,. Proc Natl Acad Sci U S A 108(45):18436\u201318441. https:\/\/doi.org\/10.1073\/pnas.1107936108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4765_CR72","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fncel.2013.00122","volume":"7","author":"AM Ferraria","year":"2013","unstructured":"Ferraria AM et al (2013) Lipocalin-2 is involved in emotional behaviors and cognitive function.,. Front Cell Neurosci 7:122\u2013122. https:\/\/doi.org\/10.3389\/fncel.2013.00122","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"4765_CR73","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/mp.2017.95","volume":"23","author":"AM Ferraria","year":"2018","unstructured":"Ferraria AM et al (2018) Lipocalin-2 regulates adult neurogenesis and contextual discriminative behaviours,. Mol Psychiatry 23(4):1031\u20131039. https:\/\/doi.org\/10.1038\/mp.2017.95","journal-title":"Mol Psychiatry"},{"issue":"2","key":"4765_CR74","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/mp.2016.243","volume":"23","author":"SS Kang","year":"2018","unstructured":"Kang SS et al (2018) Lipocalin-2 protects the brain during inflammatory conditions. Mol Psychiatry 23(2):344\u2013350. https:\/\/doi.org\/10.1038\/mp.2016.243","journal-title":"Mol Psychiatry"},{"issue":"4","key":"4765_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04831-8","volume":"13","author":"R Liu","year":"2022","unstructured":"Liu R et al (2022) NOX activation in reactive astrocytes regulates astrocytic LCN2 expression and neurodegeneration. Cell Death Dis 13(4):371. https:\/\/doi.org\/10.1038\/s41419-022-04831-8","journal-title":"Cell Death Dis"},{"issue":"4","key":"4765_CR76","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/JPER.24-0215","volume":"96","author":"DL S\u00f3lis-Suarez","year":"2025","unstructured":"S\u00f3lis-Suarez DL et al (2025) Lipocalin\u20102 as a fundamental protein in type 2 diabetes and periodontitis in mice. J Periodontol 96(4):369\u2013382. https:\/\/doi.org\/10.1002\/JPER.24-0215","journal-title":"J Periodontol"},{"issue":"12","key":"4765_CR77","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/14728222.2024.2442430","volume":"28","author":"K Suk","year":"2024","unstructured":"Suk K (2024) Lipocalin-2 as a therapeutic target for diabetes neurological complications. Expert Opin Ther Targets 28(12):1031\u20131037. https:\/\/doi.org\/10.1080\/14728222.2024.2442430","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"4765_CR78","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12291-015-0514-0","volume":"31","author":"S Tangvarasittichai","year":"2016","unstructured":"Tangvarasittichai S et al (2016) Tumor necrosis factor-\u0391, interleukin-6, C-reactive protein levels and insulin resistance associated with type 2 diabetes in abdominal obesity women. Indian J Clin Biochem 31(1):68\u201374. https:\/\/doi.org\/10.1007\/s12291-015-0514-0","journal-title":"Indian J Clin Biochem"},{"issue":"3","key":"4765_CR79","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s13311-022-01333-5","volume":"20","author":"J-H Kim","year":"2023","unstructured":"Kim J-H et al (2023) Lipocalin-2 is a key regulator of neuroinflammation in secondary traumatic and ischemic brain injury. Neurotherapeutics 20(3):803\u2013821. https:\/\/doi.org\/10.1007\/s13311-022-01333-5","journal-title":"Neurotherapeutics"},{"issue":"4","key":"4765_CR80","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/mp.2017.95","volume":"23","author":"AC Ferreira","year":"2018","unstructured":"Ferreira AC et al (2018) Lipocalin-2 regulates adult neurogenesis and contextual discriminative behaviours. Mol Psychiatry 23(4):1031\u20131039. https:\/\/doi.org\/10.1038\/mp.2017.95","journal-title":"Mol Psychiatry"},{"issue":"1","key":"4765_CR81","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41467-020-14373-2","volume":"11","author":"F Llorens","year":"2020","unstructured":"Llorens F et al (2020) Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia. Nat Commun 11(1):619\u2013619. https:\/\/doi.org\/10.1038\/s41467-020-14373-2","journal-title":"Nat Commun"},{"key":"4765_CR82","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i7.104424","author":"SX Wu","year":"2025","unstructured":"Wu SX et al (2025) Altered hippocampal subfield volumes are associated with memory and executive function in patients with type 2 diabetes mellitus. World J Diabetes. https:\/\/doi.org\/10.4239\/wjd.v16.i7.104424","journal-title":"World J Diabetes"},{"issue":"20","key":"4765_CR83","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1523\/JNEUROSCI.4261-15.2016","volume":"36","author":"B-W Kim","year":"2016","unstructured":"Kim B-W et al (2016) Pathogenic upregulation of glial Lipocalin-2 in the Parkinsonian dopaminergic system. J Neurosci 36(20):5608\u20135622. https:\/\/doi.org\/10.1523\/JNEUROSCI.4261-15.2016","journal-title":"J Neurosci"},{"key":"4765_CR84","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ibneur.2022.12.006","volume":"14","author":"M Gupta","year":"2023","unstructured":"Gupta M, Pandey S, Rumman M, Singh B, Mahdi AA (2023) Molecular mechanisms underlying hyperglycemia associated cognitive decline. IBRO Neurosci Rep 14:57\u201363. https:\/\/doi.org\/10.1016\/j.ibneur.2022.12.006","journal-title":"IBRO Neurosci Rep"},{"issue":"1","key":"4765_CR85","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/(SICI)1098-2299(199901)46:1<67::AID-DDR10>3.0.CO;2-V","volume":"46","author":"CM Anderson","year":"1999","unstructured":"Anderson CM, Anderson CM (1999) Mitochondrial dysfunction in diabetes mellitus. Drug Dev Res 46(1):67\u201379. https:\/\/doi.org\/10.1002\/(sici)1098-2299(199901)46:1%3C67::aid-ddr10%3E3.0.co;2-v","journal-title":"Drug Dev Res"},{"issue":"3","key":"4765_CR86","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2174\/156652406776894536","volume":"6","author":"T Sat\u014d","year":"2006","unstructured":"Sat\u014d T et al (2006) TAGE (toxic AGEs) theory in diabetic complications. Curr Mol Med 6(3):351\u2013358. https:\/\/doi.org\/10.2174\/156652406776894536","journal-title":"Curr Mol Med"},{"issue":"3","key":"4765_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031031","volume":"22","author":"N Niimi","year":"2021","unstructured":"Niimi N et al (2021) Aldose reductase and the polyol pathway in schwann cells: old and new problems. Int J Mol Sci 22(3):1031. https:\/\/doi.org\/10.3390\/ijms22031031","journal-title":"Int J Mol Sci\u00a0"},{"key":"4765_CR88","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fphar.2012.00087","volume":"3","author":"W Tang","year":"2012","unstructured":"Tang W, Tang W, Martin KA, Martin KA, Hwa J, Hwa J (2012) Aldose reductase, oxidative stress, and diabetic mellitus. Front Pharmacol 3:87\u201387. https:\/\/doi.org\/10.3389\/fphar.2012.00087","journal-title":"Front Pharmacol"},{"issue":"1","key":"4765_CR89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.12816\/0003082","volume":"12","author":"FA Matough","year":"2012","unstructured":"Matough FA et al (2012) The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos University Med J 12(1):5\u201318. https:\/\/doi.org\/10.12816\/0003082","journal-title":"Sultan Qaboos University Med J"},{"issue":"1","key":"4765_CR90","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1269\/jrr.06057","volume":"48","author":"MH Roudkenar","year":"2007","unstructured":"Roudkenar MH et al (2007) Oxidative stress induced lipocalin 2 gene expression: addressing its expression under the harmful conditions. J Radiat Res 48(1):39\u201344. https:\/\/doi.org\/10.1269\/jrr.06057","journal-title":"J Radiat Res"},{"key":"4765_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103148","author":"ES Shin","year":"2014","unstructured":"Shin ES et al (2014) High glucose alters retinal astrocytes phenotype through increased production of inflammatory cytokines and oxidative stress. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0103148","journal-title":"PLoS ONE"},{"issue":"11","key":"4765_CR92","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.2337\/db12-0224","volume":"61","author":"A Ceriello","year":"2012","unstructured":"Ceriello A et al (2012) Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with Type 1 Diabetes. Diabetes 61(11):2993\u20132997. https:\/\/doi.org\/10.2337\/db12-0224","journal-title":"Diabetes"},{"issue":"7","key":"4765_CR93","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2174\/1567205014666170117104053","volume":"14","author":"M Bahniwal","year":"2017","unstructured":"Bahniwal M, Bahniwal M, Little JP, Little JP, Klegeris A, Klegeris A (2017) High glucose enhances neurotoxicity and inflammatory cytokine secretion by stimulated human astrocytes. Curr Alzheimer Res 14(7):731\u2013741. https:\/\/doi.org\/10.2174\/1567205014666170117104053","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"4765_CR94","first-page":"1971","volume":"41","author":"RB Elisabeth","year":"2000","unstructured":"Elisabeth RB et al (2000) Glial reactivity, an early feature of diabetic retinopathy. Investigative Ophthalmol Visual Sci 41(7):1971\u20131980","journal-title":"Investigative Ophthalmol Visual Sci"},{"issue":"5","key":"4765_CR95","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ceca.2014.07.005","volume":"56","author":"A Verkhratsky","year":"2014","unstructured":"Verkhratsky A, Verkhratsky A, Fernyhough P, Fernyhough P, Fernyhough P (2014) Calcium signalling in sensory neurones and peripheral glia in the context of diabetic neuropathies. Cell Calcium 56(5):362\u2013371. https:\/\/doi.org\/10.1016\/j.ceca.2014.07.005","journal-title":"Cell Calcium"},{"issue":"10","key":"4765_CR96","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1210\/me.2014-1092","volume":"28","author":"H Guo","year":"2014","unstructured":"Guo H, Guo H, Jin D, Jin D, Chen X, Chen X (2014) Lipocalin 2 is a regulator of macrophage polarization and NF-\u03baB\/STAT3 pathway activation. Mol Endocrinol 28(10):1616\u20131628. https:\/\/doi.org\/10.1210\/me.2014-1092","journal-title":"Mol Endocrinol"},{"issue":"19","key":"4765_CR97","doi-asserted-by":"publisher","first-page":"14088","DOI":"10.1074\/jbc.M109.017129","volume":"285","author":"JR Karlsen","year":"2010","unstructured":"Karlsen JR, Borregaard N, Cowland JB (2010) Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with Interleukin-17 and Tumor Necrosis Factor-\u03b1 is controlled by I\u03baB-\u03b6 but neither by C\/EBP-\u03b2 nor C\/EBP-\u03b4. J Biol Chem 285(19):14088\u201314100. https:\/\/doi.org\/10.1074\/jbc.M109.017129","journal-title":"J Biol Chem"},{"issue":"5","key":"4765_CR98","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1515\/revneuro.2004.15.5.333","volume":"15","author":"RP Kesner","year":"2004","unstructured":"Kesner RP, Kesner RP, Lee I, Lee I, Gilbert PE, Gilbert PE (2004) A behavioral assessment of hippocampal function based on a subregional analysis. Rev Neurosci 15(5):333\u2013351. https:\/\/doi.org\/10.1515\/revneuro.2004.15.5.333","journal-title":"Rev Neurosci"},{"issue":"1","key":"4765_CR99","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11064-018-2634-4","volume":"44","author":"A Kumar","year":"2019","unstructured":"Kumar A, Kumar AV, Kumar A, Foster TC, Foster TC (2019) Alteration in NMDA receptor mediated glutamatergic neurotransmission in the hippocampus during senescence. Neurochem Res 44(1):38\u201348. https:\/\/doi.org\/10.1007\/s11064-018-2634-4","journal-title":"Neurochem Res"},{"issue":"7","key":"4765_CR100","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1007\/s00125-023-05907-6","volume":"66","author":"AD McNeilly","year":"2023","unstructured":"McNeilly AD et al (2023) Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes. Diabetologia 66(7):1340\u20131352. https:\/\/doi.org\/10.1007\/s00125-023-05907-6","journal-title":"Diabetologia"},{"key":"4765_CR101","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fnagi.2016.00298","volume":"8","author":"A O\u2019Shea","year":"2016","unstructured":"O\u2019Shea A et al (2016) Cognitive aging and the hippocampus in older adults. Front Aging Neurosci 8:298\u2013298. https:\/\/doi.org\/10.3389\/fnagi.2016.00298","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"4765_CR102","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/cercor\/bhi044","volume":"15","author":"N Raz","year":"2005","unstructured":"Raz N et al (2005) Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex 15(11):1676\u20131689. https:\/\/doi.org\/10.1093\/cercor\/bhi044","journal-title":"Cereb Cortex"},{"issue":"5","key":"4765_CR103","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1042\/bst0351122","volume":"35","author":"A Simi","year":"2007","unstructured":"Simi A et al (2007) Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans 35(5):1122\u20131126. https:\/\/doi.org\/10.1042\/bst0351122","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"4765_CR104","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00592-010-0218-0","volume":"47","author":"AAF Sima","year":"2010","unstructured":"Sima AAF, Sima AAF (2010) Encephalopathies: the emerging diabetic complications. Acta Diabetol 47(4):279\u2013293. https:\/\/doi.org\/10.1007\/s00592-010-0218-0","journal-title":"Acta Diabetol"},{"issue":"6301","key":"4765_CR105","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM, Ransohoff RM (2016) How neuroinflammation contributes to neurodegeneration. Science 353(6301):777\u2013783. https:\/\/doi.org\/10.1126\/science.aag2590","journal-title":"Science"},{"issue":"3","key":"4765_CR106","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/jnr.22779","volume":"90","author":"S Lee","year":"2012","unstructured":"Lee S et al (2012) Regulation by lipocalin-2 of neuronal cell death, migration, and morphology. J Neurosci Res 90(3):540\u2013550. https:\/\/doi.org\/10.1002\/jnr.22779","journal-title":"J Neurosci Res"},{"issue":"3","key":"4765_CR107","doi-asserted-by":"publisher","first-page":"276","DOI":"10.5603\/EP.a2018.0030","volume":"69","author":"W Wang","year":"2018","unstructured":"Wang W et al (2018) Podwy\u017cszone st\u0119\u017cenia lipokaliny-2 w surowicy krwi s\u0105 zwi\u0105zane ze wska\u017anikami metabolizmu glukozy i metabolizmu kostnego w przebiegu cukrzycy typu 2. Endokrynol Pol 69(3):276\u2013282. https:\/\/doi.org\/10.5603\/EP.a2018.0030","journal-title":"Endokrynol Pol"},{"key":"4765_CR108","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.diabres.2018.06.015","volume":"143","author":"J Moreno-Ulloa","year":"2018","unstructured":"Moreno-Ulloa J et al (2018) Comparison of the prevalence of metabolic syndrome and risk factors in urban and rural Mexican Tarahumara-foot runners. Diabetes Res Clin Pract 143:79\u201387. https:\/\/doi.org\/10.1016\/j.diabres.2018.06.015","journal-title":"Diabetes Res Clin Pract"},{"key":"4765_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101414","volume":"70","author":"D Dekens","year":"2021","unstructured":"Dekens D et al (2021) Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases. Ageing Res Rev 70:101414. https:\/\/doi.org\/10.1016\/j.arr.2021.101414","journal-title":"Ageing Res Rev"},{"issue":"3","key":"4765_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/cells14030159","volume":"14","author":"M Doliwa","year":"2025","unstructured":"Doliwa M et al (2025) Astrocyte-secreted Lcn2 modulates dendritic spine morphology. Cells 14(3):159. https:\/\/doi.org\/10.3390\/cells14030159","journal-title":"Cells"},{"key":"4765_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148463","volume":"1815","author":"A Horino-Shimizu","year":"2023","unstructured":"Horino-Shimizu A, Moriyama K, Mori T, Kohyama K, Nishito Y, Sakuma H (2023) Lipocalin-2 production by astrocytes in response to high concentrations of glutamate. Brain Res 1815:148463. https:\/\/doi.org\/10.1016\/j.brainres.2023.148463","journal-title":"Brain Res"},{"issue":"9","key":"4765_CR112","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/glia.23174","volume":"65","author":"JH Kim","year":"2017","unstructured":"Kim JH et al (2017) Astrocyte\u2010derived lipocalin\u20102 mediates hippocampal damage and cognitive deficits in experimental models of vascular dementia. Glia 65(9):1471\u20131490. https:\/\/doi.org\/10.1002\/glia.23174","journal-title":"Glia"},{"key":"4765_CR113","doi-asserted-by":"publisher","first-page":"101984","DOI":"10.1016\/j.arr.2023.101984","volume":"89","author":"X Li","year":"2023","unstructured":"Li X et al (2023) Association between lipocalin-2 and mild cognitive impairment or dementia: a systematic review and meta-analysis of population-based evidence. Ageing Res Rev 89:101984\u2013101984. https:\/\/doi.org\/10.1016\/j.arr.2023.101984","journal-title":"Ageing Res Rev"},{"key":"4765_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1358719","author":"Q Tan","year":"2024","unstructured":"Tan Q et al (2024) The interaction of Lipocalin-2 and astrocytes in neuroinflammation: mechanisms and therapeutic application. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1358719","journal-title":"Front Immunol"},{"key":"4765_CR115","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.pneurobio.2016.08.001","volume":"144","author":"K Suk","year":"2016","unstructured":"Suk K, Suk K (2016) Lipocalin-2 as a therapeutic target for brain injury: an astrocentric perspective. Prog Neurobiol 144:158\u2013172. https:\/\/doi.org\/10.1016\/j.pneurobio.2016.08.001","journal-title":"Prog Neurobiol"},{"issue":"5","key":"4765_CR116","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tem.2017.01.003","volume":"28","author":"AR Moschen","year":"2017","unstructured":"Moschen AR et al (2017) Lipocalin-2: a master mediator of intestinal and metabolic inflammation. Trends Endocrinol Metab 28(5):388\u2013397. https:\/\/doi.org\/10.1016\/j.tem.2017.01.003","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"4765_CR117","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1007\/s12035-021-02687-1","volume":"59","author":"J Cui","year":"2022","unstructured":"Cui J, Yuan Y, Wang J, Song N, Xie J (2022) Desferrioxamine ameliorates lipopolysaccharide-induced Lipocalin-2 upregulation via autophagy activation in primary astrocytes. Mol Neurobiol 59(4):2052\u20132067. https:\/\/doi.org\/10.1007\/s12035-021-02687-1","journal-title":"Mol Neurobiol"},{"key":"4765_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2019.104607","volume":"132","author":"DW Dekens","year":"2020","unstructured":"Dekens DW, De Deyn PP, Sap F, Eisel ULM, Naud\u00e9 PJW (2020) Iron chelators inhibit amyloid-\u03b2-induced production of lipocalin 2 in cultured astrocytes. Neurochem Int 132:104607. https:\/\/doi.org\/10.1016\/j.neuint.2019.104607","journal-title":"Neurochem Int"},{"issue":"17","key":"4765_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176253","volume":"21","author":"G Wang","year":"2020","unstructured":"Bi F et al (2013) Reactive astrocytessecrete lcn2 to promote neuron death, Proc. Natl. Acad. Sci. U.S.A., 110(10):4069\u20134074.  https:\/\/doi.org\/10.1073\/pnas.1218497110","journal-title":"IJMS"},{"issue":"1","key":"4765_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82927-1","volume":"14","author":"J Favret","year":"2024","unstructured":"Favret J et al (2024) Ablation of lipocalin-2 reduces neuroinflammation in a mouse model of Krabbe disease. Sci Rep 14(1):31822. https:\/\/doi.org\/10.1038\/s41598-024-82927-1","journal-title":"Sci Rep"},{"issue":"10","key":"4765_CR121","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1038\/s12276-023-01098-7","volume":"55","author":"B-K Jung","year":"2023","unstructured":"Jung B-K, Ryu K-Y (2023) Lipocalin-2: a therapeutic target to overcome neurodegenerative diseases by regulating reactive astrogliosis. Exp Mol Med 55(10):2138\u20132146. https:\/\/doi.org\/10.1038\/s12276-023-01098-7","journal-title":"Exp Mol Med"},{"issue":"131","key":"4765_CR122","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pneurobio.2015.06.005","volume":"131","author":"AM Ferraria","year":"2015","unstructured":"Ferraria AM et al (2015) From the periphery to the brain: Lipocalin-2, a friend or foe? Prog Neurobiol 131(131):120\u2013136. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.06.005","journal-title":"Prog Neurobiol"},{"issue":"1","key":"4765_CR123","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1038\/s41598-022-08286-x","volume":"12","author":"Kanokporn Pinyopornpanish","year":"2022","unstructured":"Pinyopornpanish Kanokporn et al (2022) Circulating Lipocalin-2 level is positively associated with cognitive impairment in patients with metabolic syndrome. Sci Rep 12(1):4635\u20134635. https:\/\/doi.org\/10.1038\/s41598-022-08286-x","journal-title":"Sci Rep"},{"issue":"7","key":"4765_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115899","volume":"44","author":"Z Huang","year":"2025","unstructured":"Huang Z et al (2025) Lipocalin-2 regulates astrocyte-oligodendrocyte interaction to drive post-stroke secondary demyelination. Cell Rep 44(7):115899. https:\/\/doi.org\/10.1016\/j.celrep.2025.115899","journal-title":"Cell Rep"},{"issue":"4","key":"4765_CR125","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/art.37840","volume":"65","author":"R Shashidharamurthy","year":"2013","unstructured":"Cui Y, Yuan J, Wang N, Song and  Xie J (2022) Desferrioxamine Ameliorates Lipopolysaccharide-Induced Lipocalin-2 Upregulation viaAutophagy Activation in Primary Astrocytes, Mol Neurobiol, 59(4):2052\u20132067.  https:\/\/doi.org\/10.1007\/s12035-021-02687-","journal-title":"Arthritis Rheum"},{"issue":"16","key":"4765_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168581","volume":"22","author":"GS Santiago-S\u00e1nchez","year":"2021","unstructured":"Santiago-S\u00e1nchez GS et al (2021) Targeting Lipocalin-2 in inflammatory breast cancer cells with small interference RNA and small molecule inhibitors. Int J Mol Sci 22(16):8581. https:\/\/doi.org\/10.3390\/ijms22168581","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4765_CR127","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.7150\/ijbs.79915","volume":"19","author":"HS An","year":"2023","unstructured":"Wang G et al (2020) Neutralization of Lipocalin-2 Diminishes Stroke-Reperfusion Injury. 21(17):6253. https:\/\/doi.org\/10.3390\/ijms21176253","journal-title":"Int J Biol Sci"},{"issue":"1","key":"4765_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82279-0","volume":"11","author":"B Bonnard","year":"2021","unstructured":"Bonnard B et al (2021) Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models. Sci Rep 11(1):2591. https:\/\/doi.org\/10.1038\/s41598-021-82279-0","journal-title":"Sci Rep"},{"issue":"1","key":"4765_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/md23010024","volume":"23","author":"N Zheng","year":"2025","unstructured":"Byung-Kwon Jung and Kwon\u2010Yul Ryu (2023) Lipocalin-2: a therapeutic target to overcome neurodegenerative diseases by regulating reactive astrogliosis, Experimental and Molecular Medicine, 55(10):2138\u20132146. https:\/\/doi.org\/10.1038\/s12276-023-01098-7","journal-title":"Mar Drugs"},{"issue":"3","key":"4765_CR130","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.molmet.2013.04.003","volume":"2","author":"P Zhao","year":"2013","unstructured":"Zhao P, Stephens JM (2013) STAT1, NF-\u03baB and ERKs play a role in the induction of lipocalin-2 expression in adipocytes. Mol Metab 2(3):161\u2013170. https:\/\/doi.org\/10.1016\/j.molmet.2013.04.003","journal-title":"Mol Metab"},{"issue":"8","key":"4765_CR131","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/gtc.12162","volume":"19","author":"A Kohda","year":"2014","unstructured":"Kohda A, Yamazaki S, Sumimoto H (2014) DNA element downstream of the \u03ba B site in the L cn2 promoter is required for transcriptional activation by I \u03ba B \u03b6 and NF - \u03ba B p50. Genes Cells 19(8):620\u2013628. https:\/\/doi.org\/10.1111\/gtc.12162","journal-title":"Genes Cells"},{"issue":"8","key":"4765_CR132","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nchembio.402","volume":"6","author":"G Bao","year":"2010","unstructured":"Bao G et al (2010) Iron traffics in circulation bound to a siderocalin (Ngal)\u2013catechol complex. Nat Chem Biol 6(8):602\u2013609. https:\/\/doi.org\/10.1038\/nchembio.402","journal-title":"Nat Chem Biol"},{"issue":"11","key":"4765_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115206","volume":"26","author":"K Nakadate","year":"2025","unstructured":"Nakadate K, Ito N, Kawakami K, Yamazaki N (2025) Anti-inflammatory actions of plant-derived compounds and prevention of chronic diseases: from molecular mechanisms to applications. IJMS 26(11):5206. https:\/\/doi.org\/10.3390\/ijms26115206","journal-title":"IJMS"},{"issue":"4","key":"4765_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26040985","volume":"26","author":"A Nani","year":"2021","unstructured":"Nani A, Murtaza B, Khan AS, Khan NA, Hichami A (2021) Antioxidant and anti-inflammatory potential of polyphenols contained in Mediterranean Diet in obesity: molecular mechanisms. Molecules 26(4):985. https:\/\/doi.org\/10.3390\/molecules26040985","journal-title":"Molecules"},{"issue":"10","key":"4765_CR135","doi-asserted-by":"publisher","first-page":"13859","DOI":"10.18632\/aging.202980","volume":"13","author":"Y He","year":"2021","unstructured":"He Y et al (2021) Curcumin inhibits the proliferation and migration of vascular smooth muscle cells by targeting the chemerin \/ CMKLR1 \/ LCN2 axis. Aging 13(10):13859\u201313875. https:\/\/doi.org\/10.18632\/aging.202980","journal-title":"Aging"},{"issue":"4","key":"4765_CR136","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ajpath.2015.12.004","volume":"186","author":"BS Yeoh","year":"2016","unstructured":"Yeoh BS et al (2016) Epigallocatechin-3-Gallate inhibition of myeloperoxidase and its counter-regulation by dietary iron and lipocalin 2 in murine model of gut inflammation. Am J Pathol 186(4):912\u2013926. https:\/\/doi.org\/10.1016\/j.ajpath.2015.12.004","journal-title":"Am J Pathol"},{"key":"4765_CR137","doi-asserted-by":"publisher","first-page":"607685","DOI":"10.3389\/fnagi.2020.607685","volume":"12","author":"A Joseph","year":"2021","unstructured":"Joseph A, McQuail et al (2021) Cognitive Reserve in Model Systems for Mechanistic Discovery: The Importance of Longitudinal Studies. Front Aging Neurosci 12:607685\u2013607685. https:\/\/doi.org\/10.3389\/fnagi.2020.607685","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"4765_CR138","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40413-018-0201-8","volume":"11","author":"F Roth-Walter","year":"2018","unstructured":"Roth-Walter F et al (2018) Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot study. World Allergy Organ J 11(1):21\u201321. https:\/\/doi.org\/10.1186\/s40413-018-0201-8","journal-title":"World Allergy Organ J"},{"issue":"4","key":"4765_CR139","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/glia.23942","volume":"69","author":"A Bhusal","year":"2020","unstructured":"Bhusal A et al (2020) Satellite glia as a critical component of diabetic neuropathy: role of lipocalin-2 and pyruvate dehydrogenase kinase-2 axis in the dorsal root ganglion. Glia 69(4):971\u2013996. https:\/\/doi.org\/10.1002\/glia.23942","journal-title":"Glia"},{"issue":"5","key":"4765_CR140","doi-asserted-by":"publisher","first-page":"e0285553","DOI":"10.1371\/journal.pone.0285553","volume":"18","author":"H Cuevas","year":"2023","unstructured":"Cuevas H, Stuifbergen AK, Hilsabeck RC, Sales A, Wood SJ, Kim J (2023) The role of cognitive rehabilitation in people with type 2 diabetes: a study protocol for a randomized controlled trial. PLoS One 18(5):e0285553\u2013e0285553. https:\/\/doi.org\/10.1371\/journal.pone.0285553","journal-title":"PLoS One"},{"issue":"7","key":"4765_CR141","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/brainsci12070878","volume":"12","author":"H-J Shin","year":"2022","unstructured":"Shin H-J et al (2022) Lipocalin-2 deficiency reduces hepatic and hippocampal Triggering Receptor Expressed on Myeloid Cells-2 expressions in high-fat diet\/Streptozotocin-induced diabetic mice. Brain Sci 12(7):878\u2013878. https:\/\/doi.org\/10.3390\/brainsci12070878","journal-title":"Brain Sci"},{"key":"4765_CR142","doi-asserted-by":"publisher","first-page":"113626","DOI":"10.1016\/j.bcp.2019.113626","volume":"169","author":"A Bhusal","year":"2019","unstructured":"Bhusal A et al (2019) Paradoxical role of lipocalin-2 in metabolic disorders and neurological complications. Biochem Pharmacol 169:113626\u2013113626. https:\/\/doi.org\/10.1016\/j.bcp.2019.113626","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"4765_CR143","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.4161\/cc.5.11.2773","volume":"5","author":"CC Fraser","year":"2006","unstructured":"Fraser CC (2006) Exploring the positive and negative consequences of NF-&kappa;B inhibition for the treatment of human disease. Cell Cycle 5(11):1160\u20131163. https:\/\/doi.org\/10.4161\/cc.5.11.2773","journal-title":"Cell Cycle"},{"issue":"1","key":"4765_CR144","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13045-021-01087-1","volume":"14","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Yue P, Lu T, Wang Y, Wei Y, Wei X (2021) Role of lysosomes in physiological activities, diseases, and therapy. J Hematol Oncol 14(1):79. https:\/\/doi.org\/10.1186\/s13045-021-01087-1","journal-title":"J Hematol Oncol"},{"issue":"9","key":"4765_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092587","volume":"11","author":"BS Sivamaruthi","year":"2023","unstructured":"Sivamaruthi BS et al (2023) NF-\u03baB pathway and its inhibitors: A promising frontier in the management of Alzheimer\u2019s disease. Biomedicines 11(9):2587. https:\/\/doi.org\/10.3390\/biomedicines11092587","journal-title":"Biomedicines"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04765-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-026-04765-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04765-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:24:25Z","timestamp":1782707065000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-026-04765-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":145,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4765"],"URL":"https:\/\/doi.org\/10.1007\/s11064-026-04765-z","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"150"}}